Webinars
Introducing human iPSC derived muscle cells for research and drug discovery
Dr Will Bernard, Senior Scientist, bit.bio
Dr Luke Flatt, Senior Scientist, Charles River
bit.bio
Consistent and scalable human iPSC-derived cells for in vitro disease modelling and drug discovery
Kam Dhaliwal, SVP Strategic Alliances
Dr Thomas Moreau, Head of Research
bit.bio talk at ELRIG
Solving the R&D efficiency conundrum within Drug Discovery: Thoughts, Insights and Solutions
bit.bio panel discussion at ELRIG
Advances in cellular reprogramming: from stem cells to printed tissues
Prof Hagan Bayley, University of Oxford
Dr Mark Kotter, Founder and CEO bit.bio
bit.bio
Discover more resources
Webinars
Posters
Journals
